Stacy W. Blain

5.2k total citations · 1 hit paper
29 papers, 3.4k citations indexed

About

Stacy W. Blain is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stacy W. Blain has authored 29 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stacy W. Blain's work include Cancer-related Molecular Pathways (14 papers), Advanced Breast Cancer Therapies (9 papers) and HIV Research and Treatment (6 papers). Stacy W. Blain is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Advanced Breast Cancer Therapies (9 papers) and HIV Research and Treatment (6 papers). Stacy W. Blain collaborates with scholars based in United States and Germany. Stacy W. Blain's co-authors include Joan Massagué, Roger S. Lo, Stephen P. Goff, Joan Seoane, Melissa K. James, Alice Telesnitsky, Andrew Koff, Howard I. Scher, Carlos Cordon‐Cardo and Robert P. Fisher and has published in prestigious journals such as Cell, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Stacy W. Blain

26 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders

2000 2.0k citations Joan Massagué, Stacy W. Blain et al. Cell profile →

Peers

Stacy W. Blain

ONCOL

PRM

Kunxin Luo United States

Tanja Veikkola Finland

Michèle Grieco Italy

Kolja Eppert Canada

Eric S. Martin United States

David W. Goodrich United States

Aart G. Jochemsen Netherlands

Frank Bartel Germany

Eduardo Firpo United States

Ewan R. Cameron United Kingdom

Kunxin Luo United States

Stacy W. Blain

5.0k ×2.0

1.2k ×0.9

ONCOL

739 ×1.6

252 ×0.6

PRM

556 ×1.7

Citations per year, relative to Stacy W. Blain Stacy W. Blain (= 1×) peers Kunxin Luo

Countries citing papers authored by Stacy W. Blain

Since Specialization

Citations

This map shows the geographic impact of Stacy W. Blain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy W. Blain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy W. Blain more than expected).

Fields of papers citing papers by Stacy W. Blain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy W. Blain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy W. Blain. The network helps show where Stacy W. Blain may publish in the future.

Co-authorship network of co-authors of Stacy W. Blain

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy W. Blain. A scholar is included among the top collaborators of Stacy W. Blain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy W. Blain. Stacy W. Blain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Grace, et al.. (2024). Abstract LB265: IpY.20: Innovative strategies for post-CDK estrogen receptor (ER)+ metastatic breast cancer (mBC). Cancer Research. 84(7_Supplement). LB265–LB265.

Chen, Grace, Natalia Zisman, Krishna P. Allamneni, & Stacy W. Blain. (2024). Abstract B018: Triple CDK2/4/6 inhibition via p27 modulation: A novel approach to targeting cell cycle dysregulation. Cancer Research. 84(3_Supplement_1). B018–B018.

Chen, Grace, et al.. (2022). Abstract P5-16-18: Developing IpY: A novel inhibitor for the treatment of ER+ CDK4i-resistant breast cancer. Cancer Research. 82(4_Supplement). P5–16.

Chen, Grace, Manasi P. Jogalekar, Vladislav Tsiperson, et al.. (2021). NP-ALT, a Liposomal:Peptide Drug, Blocks p27Kip1 Phosphorylation to Induce Oxidative Stress, Necroptosis, and Regression in Therapy-Resistant Breast Cancer Cells. Molecular Cancer Research. 19(11). 1929–1945. 8 indexed citations

Nataraj, Sarah & Stacy W. Blain. (2021). A cyclin D-CDK6 dimer helps to reshuffle cyclin-dependent kinase inhibitors (CKI) to overcome TGF-beta-mediated arrest and maintain CDK2 activity. Cell Cycle. 20(8). 808–818. 4 indexed citations

Tsiperson, Vladislav, et al.. (2018). Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells. Molecular Cancer Research. 16(3). 361–377. 51 indexed citations

Gottesman, Susan, Jonathan Somma, Vladislav Tsiperson, et al.. (2018). Tyrosine Phosphorylation of p27Kip1 Correlates with Palbociclib Responsiveness in Breast Cancer Tumor Cells Grown in Explant Culture. Molecular Cancer Research. 17(3). 669–675. 13 indexed citations

Joseph, Danielle, et al.. (2018). Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells. PLoS ONE. 13(11). e0206368–e0206368. 6 indexed citations

Asbach, Benedikt, et al.. (2015). Brk/Protein Tyrosine Kinase 6 Phosphorylates p27 ^KIP1 , Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4. Molecular and Cellular Biology. 35(9). 1506–1522. 35 indexed citations

10.

Liu, Yuhui, et al.. (2012). Tyrosine Phosphorylation of the p21 Cyclin-dependent Kinase Inhibitor Facilitates the Development of Proneural Glioma. Journal of Biological Chemistry. 287(46). 38523–38530. 16 indexed citations

11.

Blain, Stacy W., et al.. (2011). Chk1 has an essential role in the survival of differentiated cortical neurons in the absence of DNA damage. APOPTOSIS. 16(5). 449–459. 11 indexed citations

12.

Ye, W. & Stacy W. Blain. (2010). S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons. Brain. 133(8). 2295–2312. 25 indexed citations

13.

James, Melissa K., et al.. (2008). p27 ^Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes. Molecular and Cellular Biology. 29(4). 986–999. 97 indexed citations

14.

James, Melissa K., et al.. (2007). Differential Modification of p27 ^Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity. Molecular and Cellular Biology. 28(1). 498–510. 105 indexed citations

15.

Blain, Stacy W., Howard I. Scher, Carlos Cordon‐Cardo, & Andrew Koff. (2003). p27 as a target for cancer therapeutics. Cancer Cell. 3(2). 111–115. 123 indexed citations

16.

Blain, Stacy W. & Joan Massagué. (2000). Different Sensitivity of the Transforming Growth Factor-β Cell Cycle Arrest Pathway to c-Myc and MDM-2. Journal of Biological Chemistry. 275(41). 32066–32070. 22 indexed citations

17.

Massagué, Joan, Stacy W. Blain, & Roger S. Lo. (2000). TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders. Cell. 103(2). 295–309. 2015 indexed citations breakdown →

18.

Blain, Stacy W., et al.. (1997). Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4. Journal of Biological Chemistry. 272(41). 25863–25872. 243 indexed citations

19.

Telesnitsky, Alice, Stacy W. Blain, & Stephen P. Goff. (1995). [27] Assays for retroviral reverse transcriptase. Methods in enzymology on CD-ROM/Methods in enzymology. 262. 347–362. 62 indexed citations

20.

Blain, Stacy W. & Stephen P. Goff. (1993). Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.. Journal of Biological Chemistry. 268(31). 23585–23592. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact